BioSpace News Archive

Pharm Country

Applied DNA to Showcase Linea(TM) DNA and Linea(TM) IVT Platforms at 24th Annual World Vaccine Congress

Applied DNA Sciences, Inc., a leader in PCR-based DNA technologies, will showcase its Linea™ IVT and Linea™ DNA platforms at the 24th Annual World Vaccine Congress, which will be held April 1 - 4, 2024.

March 14, 2024
·
3 min read
BioMidwest

Dr. Jody Douglas Berry Joins NOWDiagnostics as Chief Scientific Officer

NOWDiagnostics announced the appointment of Jody Douglas Berry, Ph.D. as chief scientific officer.

March 14, 2024
·
3 min read
Drug Development

HepaRegeniX publishes data for its first-in-class MKK4 inhibitor HRX-215 for the treatment of acute and chronic liver diseases in Cell

HepaRegeniX GmbH, a clinical stage company developing novel regenerative therapies for the treatment of acute and chronic liver diseases, today published clinical and preclinical results on its first-in-class MKK4 inhibitor HRX-215 in the prestigious journal Cell.

March 14, 2024
·
4 min read
Bio NC

Glioblastoma Foundation to Be Official Charity Partner of the 2024 Los Angeles Marathon

The Glioblastoma Foundation is proud to be a charity partner for the 2024 Los Angeles Marathon for the 5th year.

March 14, 2024
·
2 min read
Business

Enliven Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update

Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN) today reported financial results for the fourth quarter and full year ended December 31, 2023, provided updated guidance on parallel lead product candidates and highlighted pipeline progress.

March 14, 2024
·
9 min read
Business

Sisram Medical to Report FY2023 Financial Results on March 20 and Hold a Conference Call on March 21

Sisram Medical Ltd today announced that it expects to release its annual results for FY2023, ended December 31, on Wednesday, March 20, 2024.

March 14, 2024
·
1 min read
Inside information: Bioretec has been granted FDA Breakthrough Device Designation status for its RemeOs™ Spinal Interbody Cage

Bioretec Ltd. has today been granted Breakthrough Device Designation for its RemeOs™ Spinal Interbody Cage implant from the US Food and Drug Administration, confirming that the product represents a breakthrough technology in spinal surgery.

March 14, 2024
·
3 min read
BioMidwest

Cellipont Bioservices and Wugen Sign Agreement for the Clinical Manufacture of Wugen’s Off-the-shelf CAR-T Cellular Therapies

Cellipont Bioservices and Wugen, Inc., a clinical-stage biotechnology company developing allogeneic, off-the-shelf cell therapies to treat a broad range of hematological and solid tumor malignancies, today announced the signing of an agreement for the manufacturing of their CAR-T cell therapies.

March 14, 2024
·
2 min read
TrialAssure Launches Anonymize 3.0 Technology for an Improved Data and Document Anonymization User Experience in Pharma and Beyond

TrialAssure, a leading pharmaceutical technology provider advancing clinical trial disclosure, data sharing, and transparency, announced that its flagship product TrialAssure ANONYMIZE®

March 14, 2024
·
3 min read
Drug Development

Cantargia Presents New Human Data Further Supporting CAN10 in the Treatment of Systemic Sclerosis

Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm:CANTA) today reported new data highlighting the potential of the CAN10 antibody, currently in phase I clinical development, as therapy in systemic sclerosis.

March 14, 2024
·
5 min read